Second Sight wins go-ahead for German Argus II study in better-sighted RP
  patients
From: Mass Device - 10/17/2017
By: Fink Densford

Second Sight Medical said today it won approval from Germany's BfArM
regulatory body to initiate a 10-patient study exploring the use of its Argus
II retinal prosthesis system in better sighted retinitis pigmentosa patients
and individuals with tunnel vision.

The Argus II induces visual perception in patients with retinitis pigmentosa
by stimulating of the retina’s remaining cells with electrical pulses, which
allows for the perception of light patterns to the brain, the Sylmar, CA
based company said.

The clinical trial will take place at 3 sites across Germany, the company
said, with a primary endpoint evaluating improvement of the visual field
added by the Argus II for RP patients with tunnel vision.

A secondary endpoint will evaluate how well patients treated with the Argus
II integrate the system into daily life, Second Sight said.

Read the entire article at:
http://www.massdevice.com/second-sight-wins-go-ahead-german-argus-ii-study-better-sighted-rp-patients

Links:
Second Sight
http://www.secondsight.com

Second Sight Receives Approval ...
http://www.businesswire.com/news/home/20171017005227/en/Sight-Receives-Approval-Bundesinstitut-f%C3%BCr-Arzneimittel-und

Second Sight Medical wins expanded CMS coverage for Argus II
http://www.massdevice.com/second-sight-medical-wins-expanded-cms-coverage-argus-ii

Related:
Pixium Vision wins French approval for Prima sub-retinal implant study
http://www.massdevice.com/pixium-vision-wins-french-approval-prima-sub-retinal-implant-study